PharmAust advances monepantel for motor neurone disease towards FDA approval

By Proactive Investors / February 23, 2024 / www.youtube.com / Article Link


PharmAust Limited (ASX:PAA) CEO Dr Michael Thurn tells Proactive's Stephen Gunnion that the company had a "pivotal" ...

Recent News

Equity highs and low credit spreads may be warning signs
August 10, 2026 / www.canadianminingreport.com

Gold stocks see strongest week in a decade
August 10, 2026 / www.canadianminingreport.com

Big Gold's strong Q2/26 results continue
August 03, 2026 / www.canadianminingreport.com

Gold stocks see moderate declines

August 03, 2026 / www.canadianminingreport.com

Market still expecting strong growth for major gold producers
July 27, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok